Publication Cover
Synthetic Communications
An International Journal for Rapid Communication of Synthetic Organic Chemistry
Volume 52, 2022 - Issue 6
410
Views
3
CrossRef citations to date
0
Altmetric
Articles

Synthesis of some novel 1,3,4-oxadiazole derivatives and evaluation of their antimicrobial activity

ORCID Icon, , &
Pages 926-935 | Received 31 Jan 2022, Published online: 11 Apr 2022

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Fengwen Huang & Chen Chen. (2024) Investigation of Bucillamine as anti-COVID-19 drug: DFT study, molecular docking, molecular dynamic simulation and ADMET analysis. Journal of Biomolecular Structure and Dynamics 42:1, pages 34-42.
Read now

Articles from other publishers (2)

Saima Daud, Obaid-ur-Rahman Abid, Wajid Rehman, Maryam Niaz, Asma Sardar, Liaqat Rasheed, Basit Niaz, Basit Ali Shah, Hadil Faris Alotaibi, Ahmad J. Obaidullah & Mohammed M. Alanazi. (2023) In vitro evaluation of novel mefenamic acid derivatives as potential α-glucosidase and urease inhibitors: Design, synthesis, in silico and cytotoxic studies. Journal of Saudi Chemical Society 27:4, pages 101680.
Crossref
Juan Sun, Cui‐Ping Zhang, Chong‐Hao Chen, Xiao‐Meng Guo, Cai‐Shi Liu, Yang Zhou & Fu‐Liang Hu. (2023) Design, Synthesis and Molecular Docking of 1,3,4‐Oxadiazole‐2(3 H )‐thione Derivatives Containing 1,4‐Benzodioxane Skeleton as Potential FabH Inhibitors . Chemistry & Biodiversity 20:2.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.